199 related articles for article (PubMed ID: 16339696)
21. Genetics of osteoporosis.
Ralston SH
Ann N Y Acad Sci; 2010 Mar; 1192():181-9. PubMed ID: 20392235
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and risk of osteopenia in β-thalassemia major patients.
Sahmani M; Gholami A; Azarkeivan A; Darabi M; Ahmadi MH; Sabet MS; Najafipour R
Hemoglobin; 2013; 37(6):564-73. PubMed ID: 23909657
[TBL] [Abstract][Full Text] [Related]
23. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
[TBL] [Abstract][Full Text] [Related]
24. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Konstandelou E; Tolis G
Pediatr Hematol Oncol; 2007; 24(7):481-91. PubMed ID: 17786784
[TBL] [Abstract][Full Text] [Related]
25. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.
Voskaridou E; Terpos E
Br J Haematol; 2004 Oct; 127(2):127-39. PubMed ID: 15461618
[TBL] [Abstract][Full Text] [Related]
26. Genetic regulation of bone mass and susceptibility to osteoporosis.
Ralston SH; de Crombrugghe B
Genes Dev; 2006 Sep; 20(18):2492-506. PubMed ID: 16980579
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
Mokhtar GM; Tantawy AA; Adly AA; Ismail EA
Hemoglobin; 2011; 35(4):382-405. PubMed ID: 21797705
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis and management of osteoporosis in thalassemia.
Voskaridou E; Terpos E
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():86-93. PubMed ID: 19337161
[TBL] [Abstract][Full Text] [Related]
29. The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes.
Castellani C; Malerba G; Sangalli A; Delmarco A; Petrelli E; Rossini M; Assael BM; Mottes M
J Cyst Fibros; 2006 Dec; 5(4):229-35. PubMed ID: 16713399
[TBL] [Abstract][Full Text] [Related]
30. Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment.
De Sanctis V; Soliman AT; Elsedfy H; Yassin M; Canatan D; Kilinc Y; Sobti P; Skordis N; Karimi M; Raiola G; Galati MC; Bedair E; Fiscina B; El Kholy M;
Pediatr Endocrinol Rev; 2013 Dec; 11(2):167-80. PubMed ID: 24575552
[TBL] [Abstract][Full Text] [Related]
31. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia.
Napoli N; Carmina E; Bucchieri S; Sferrazza C; Rini GB; Di Fede G
Bone; 2006 Jun; 38(6):888-92. PubMed ID: 16464653
[TBL] [Abstract][Full Text] [Related]
32. [Osteopenia in beta-thalassemia major].
Brändle M; Galeazzi RL; Morant R; Oesterle M
Schweiz Med Wochenschr; 1996 Nov; 126(44):1867-74. PubMed ID: 8984599
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: the role of the RANKL/osteoprotegerin axis.
Voskaridou E; Stoupa E; Antoniadou L; Premetis E; Konstantopoulos K; Papassotiriou I; Terpos E
Haematologica; 2006 Jun; 91(6):813-6. PubMed ID: 16704959
[TBL] [Abstract][Full Text] [Related]
34. The bone density of thalassemic patients of Boo Ali Sina Hospital, Sari, Iran in 2002 does hydroxyurea help?
Kosaryan M; Zadeh MF; Shahi VK
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():303-6. PubMed ID: 16462716
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral density in beta-thalassemia major and intermedia.
Karimi M; Ghiam AF; Hashemi A; Alinejad S; Soweid M; Kashef S
Indian Pediatr; 2007 Jan; 44(1):29-32. PubMed ID: 17277428
[TBL] [Abstract][Full Text] [Related]
36. Osteoporosis: genetic analysis of multifactorial disease.
Zajickova K; Zofkova I
Endocr Regul; 2003 Mar; 37(1):31-44. PubMed ID: 12916320
[TBL] [Abstract][Full Text] [Related]
37. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
38. Recent advances in the genetics of osteoporosis.
Williams FM; Spector TD
J Musculoskelet Neuronal Interact; 2006; 6(1):27-35. PubMed ID: 16675887
[TBL] [Abstract][Full Text] [Related]
39. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density.
Mencej-Bedrac S; Prezelj J; Kocjan T; Teskac K; Ostanek B; Smelcer M; Marc J
J Mol Endocrinol; 2009 Mar; 42(3):239-47. PubMed ID: 19131500
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
Nguyen TV; Center JR; Eisman JA
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
